In the human hematopoietic system, rare self-renewing multi-potent long-term hematopoietic stem cells (LT-HSCs) are responsible for the lifelong production of mature blood cells and are the rational target for clinical regenerative therapies.
Abstract:
In the human hematopoietic system, rare self-renewing multi-potent long-term hematopoietic stem cells (LT-HSCs) are responsible for the lifelong production of mature blood cells and are the rational target for clinical regenerative therapies.
However, the heterogeneity in the hematopoietic stem cell compartment and variable outcomes of CRISPR/Cas9 editing make functional interrogation of rare LTHSCs challenging. Here, we report high efficiency LT-HSC editing at single cell resolution using electroporation of modified synthetic gRNAs and Cas9 protein.
Targeted short isoform expression of the GATA1 transcription factor elicited distinct differentiation and proliferation effects in single LT-HSC when analyzed with functional in vitro differentiation and long-term repopulation xenotransplantation assays. Our method represents a blueprint for systematic genetic analysis of complex tissue hierarchies at single cell level.
Introduction:
The hematopoietic stem and progenitor cell (HSPC) compartment is a functional continuum comprised of multiple stem and progenitor cell populations including abundant committed progenitors such as common myeloid progenitors (CMPs) and myelo-erythroid progenitors (MEPs), as well as rarer multipotent stem cells including short-term hematopoietic stem cells (ST-HSCs) and long-term hematopoietic stem cells (LT-HSCs, Supplementary Fig. 1 ) 1,2 . LT-HSCs are the only population that have the ability to permanently repopulate the entire hematopoietic system following transplantation 2 ; they represent the key target for blood-based regenerative therapies. Thus, LT-HSCs are essential for therapeutic genome editing to correct acquired and genetic hematopoietic disorders 3, 4 . Furthermore, the pathogenesis of hematological malignancies like acute myeloid leukemia (AML) is associated with the presence of initiating mutations acquired in LT-HSCs, which lead to their competitive expansion 5, 6 . Pre-leukemic LT-HSCs are a source of clonal evolution within blood malignancies and can act as a reservoir of relapse after chemotherapy treatment 7 . Thus, modeling and understanding the genetic complexity and cellular heterogeneity seen in human hematological malignancies requires novel methodologies that allow genome editing in LT-HSCs and their functional read-out 3, 4 .
(bone marrow -BM). Only mice with human CD45 + engraftment levels of >5% in the RF and >90% CRISPR/Cas9 editing efficiency as determined by PCR and Sanger sequencing were included in our analysis: 40% of control mice and 35% of mice transplanted with GATA1-Short edited LT-HSCs fulfilled these criteria (Fig. 3a,   Supplementary Fig. 5b-e) . To precisely determine the genotype of the clonal progeny of injected LT-HSCs, secondary methylcellulose colony formation assays from cells of the RF were carried out. Analysis of CRISPR/Cas9 edits in individual colonies by Sanger sequencing revealed clonal engraftment in 3 out of 5 GATA1-Short edited LT-HSCs injected mice, highlighting that the xenotransplantations were indeed performed at a near clonal level ( Supplementary Fig. 6 ). On average, human CD45 + engraftment in the RF was 40%, both in control and GATA1-Short edited LTHSCs injected mice (Fig. 3b) . Interestingly, GATA1-Short edited LT-HSCs generated grafts with 2-fold higher percentage of human CD41 + CD45 -megakaryocytes in the RF compared to controls (Fig. 3c ). In addition, we observed an increase in the percentage of human CD19 + CD45 + B-lymphoid cells in the RF at the expense of myeloid cells in these grafts (Fig. 3d, Supplementary Fig. 7a-d ). GATA1-Short edited LT-HSCs generated grafts with higher absolute cell numbers, mainly due to increased numbers of B-lymphoid lineage cells (Fig. 3e, Supplementary Fig. 7e-i) .
The observed increase in megakaryocytic output in mice transplanted with GATA1-Short edited LT-HSCs (Fig. 3f ) confirms our single cell in vitro findings, and demonstrates the feasibility of conducting near-clonal xenotransplantation assays using purified CRISPR/Cas9-edited LT-HSCs.
Normal human HSCs show a predominant B-lymphoid bias upon long-term engraftment in NSG mice 25 . We therefore repeated our xenotransplantation assays using c-kit-deficient NSGW41 recipients, which support enhanced erythropoiesis and megakaryocyte formation 26 . Limiting dilution analysis of CRISPR/Cas9-edited LT-HSCs in NSGW41 mice for 12 weeks revealed a repopulating cell frequency of ~1/175, compared to ~1/100 in the NSG background for 24 weeks ( Supplementary   Fig. 8a ). Consequently, an equivalent dose of 200-250 control-or GATA1-Shortedited LT-HSCs were transplanted into NSGW41 mice and human engraftment in the RF and BM was analyzed after 12 weeks. 35% of mice transplanted with control edited LT-HSCs and 30% of mice transplanted with GATA1-Short edited LT-HSCs showed robust engraftment and successful CRISPR/Cas9 editing (Fig. 4a,   Supplementary Fig. 8b, c) . Human CD45 + engraftment was observed at similar high levels as in NSG mice (Fig. 4b) . Strikingly, a 5-fold increase in megakaryocytic output was observed in the RF and BM of mice transplanted with GATA1-Short edited LTHSCs (Fig. 4c) . No changes were seen in the percentage of B-lymphoid cells, but a decrease in human GlyA + CD45 -erythroid cells was detected in mice transplanted with GATA1-Short edited LT-HSCs (Fig. 4d, Supplementary Fig. 9a, b) . Analysis of total cell numbers revealed a similar pattern, including a 3-fold increase in the number of megakaryocytes and, at the same time, a 6-fold reduction in erythroid cell numbers (Fig. 4e, Supplementary Fig. 9c-g ). There were no differences in Blymphoid proliferation in grafts generated by control-and GATA1-Short edited LTHSCs in NSGW41 mice, in contrast to our observations in NSG recipients, which was possibly due to the reduced lymphoid bias observed in NSGW41 mice. In summary, xenotransplantation into NSGW41 mice further augmented the megakaryocytic output of GATA1-Short edited LT-HSCs in vivo, with a concomitant decrease in erythroid cells (Fig. 4f) .
Discussion:
In conclusion, we demonstrate that isolated LT-HSCs as well as more committed stem and progenitor cells can be edited with high efficiency using CRISPR/Cas9. Aside from showing how a prototypical transcription factor functions in regulating lineage fate in LT-HSCs, this result is of great importance in modeling the first step in human Down Syndrome AMKL. Our method opens up the possibility of studying gene function relationships not only in LT-HSCs, but also in other stem and progenitor cells to uncover cell type specific phenotypes. We believe that the continuous improvement of CRISPR/Cas9 editing efficiency, for example through chemically modified gRNAs [27] [28] [29] or different Cas9 variants 30,31 , will further improve this approach. In the future, we envision that this method could potentially be adapted for cellular therapies. 
Methods

Cord blood lineage depletion
Cord blood sorting
Lineage depleted cells were thawed via slow dropwise addition of X-VIVO 10 (Lonza, 04743Q) with 50% FBS (Sigma, 15A085) and DNaseI (200 ug/ml, Roche, 10104159001). Cells were spun at 1450RPM for 10 min at 4°C and then resuspended in PBS + 2.5% FBS. For all in vitro and in vivo experiments, the full stem and progenitor hierarchy sort as described in Notta et al 22 Fig. 1b) . For GATA1 Long, gRNA sequences closest to the second ATG start codon were individually tested for cleavage efficiency and the best gRNA was selected. The GATA1 Long HDR template was designed with 60 bp homology ends at either side. For the template, the ATG (Methionine) start codon was mutated to CTC (Leucine) and the PAM sequence was mutated from GGG (Glycine) to GGC (Glycine) in order to avoid repeated cutting by the gRNA (Fig. 1c) . The control gRNAs, which target exon 1 of the olfactory receptor OR2W5, were predicted by the CRoatan algrotihm 21 . The STAG2 gRNA was predicted with the same algorithm. 
Setup of a single cell in vitro assay
Single cell in vitro assays were performed according to Notta et al. 22 
Flow cytometry of single cell in vitro assay
Wells with hematopoietic cell content were marked one day prior and the total number of wells with colonies was used to assess CRISPR/Cas9 and single cell colony efficiencies. On the day of analysis, 140µl of media was removed from each well with a multi-channel pipette and the content was mixed well. Upon additional washing of the wells with PBS, the content in each well was transferred to a 96 well filter plate (8027, Pall) in order to remove stromal cells. For this, the filter plate was put on top of a 96 well U-bottom plate (Corning, 351177) and centrifuged at 1360RPM for 7 min at room temperature. After the cells were pelleted at the bottom of the U-bottom plate, the media was tossed by quickly inverting the U-bottom plate (~20ul of liquid per well remained). Then, 30µl of PBS + 2.5% FBS was added and mixed into each well with a multi-channel pipette and 25µl (half) was transferred to a 96 well PCR plate (Eppendorf, 951020362) for subsequent genomic DNA extraction (the PCR plate was sealed and stored at -80C). After that, 25µl of antibody mix in PBS + 2.5% FBS was added to each well, containing 25µl of hematopoietic 
Genotyping of single cell in vitro assay
The PCR plates containing 25µl of cells per well were thawed and a modified protocol of the Agencourt GenFind V2 (Beckman Coulter, A41499) was utilized to isolate genomic DNA. Wells with cell content were transferred to a new 96 well PCR plate (Eppendorf, 951020362) in order to utilize multi-channel pipetting for each future step. 25µl of lysis buffer and 1.2µl of Proteinase K (Zymo Research, D3001220) were pipetted into each well. After 30 min at room temperature, 50µl of magnetic particles were added. After 5 min, the PCR plate was placed on a magnetic stand (ThermoFisher, AM10027) for 10 min. The supernatant was removed with a multi-channel pipette and the plate was taken off the magnet. 200µl of wash buffer 1 were mixed into each well and the PCR plate was put back onto the magnetic stand.
After 10 min, the supernatant was removed and each well was washed with 125µl of wash buffer 2. Finally, after the last wash buffer was removed, the magnetic particles were resuspended with 60µl of TE buffer (IDT). The PCR plate was put back on the magnetic stand and after 10 min, 57µl of eluted genomic DNA was removed and put into a new PCR plate.
The CRISPR/Cas9 engineered genomic locus was amplified via PCR. For each PCR reaction, 23µl of eluted genomic DNA was mixed with 1µl of forward and reverse primer (10µM) and 25µl of AmpliTaq Gold 360 Master Mix (ThermoFisher, 4398881). The PCR program was: 95°C for 10 min, followed by 95°C for 30s, 56°C for 30s and 72°C for 1 min (40 cycles) and then 72°C for 7 min. To identify colonies with the GATA1-Short genotype, 15µl of PCR product was run on a 1.5% agarose gel (ThermoFisher, 16500500). Control gRNA colonies were screened for homozygous deletion of OR2W5 (deletion within exon 1, 700bp to 500bp, (Supplementary Fig.   3a ). Similarly, GATA1-Short colonies were screened for a shift in the size of the PCR product (deletion of exon 2, 1000 bp to 550 bp, Supplementary Fig. 3b ). In order to identify colonies with the GATA1-Long genotype, PCR products were column purified using the ZR-96 DNA Clean-up Kit (Zymo Research, D4018) according to the manufacturer's protocol. The purified PCR product was Sanger sequenced using the reverse PCR primer and the chromatograms were inspected to identify colonies that contained the alternative start site mutation (Supplementary Fig. 3c ). Finally, to identify STAG2 knock-out colonies, PCR products were column purified and sent for Sanger sequencing using the reverse PCR primer. Only colonies that showed a frame shift mutation were considered positive ( Supplementary Fig. 4c ).
PCR primers:
Animal studies
All mouse experiments were approved by the University Health Network (UHN) 25µl of cells were used for flow cytometry analysis and another 25µl were frozen down for genomic DNA isolation in order to verify CRISPR/Cas9 edits (same protocol as above for single cell in vitro assays).
Limiting dilution in vivo assays
For limiting dilution transplantation assays, CRISPR/Cas9 control gRNA electroporated LT-HSCs were injected at defined doses (equivalent to 25, 50, 100 and 200 LT-HSCs) into 8-to 12-week-old female NSG or NSGW41 mice. LT-HSC cell numbers were based on the number of flow cytometry sorted cells at day 0. LT-HSC frequency was estimated using the online tool ELDA (http://bioinf.wehi.edu.au/software/elda/index.html) 24 .
Flow cytometry of in vivo assays
Cells 
CRISPR/Cas9 efficiency in electroporated cells and engrafted mice
After each CRISPR/Cas9 RNP electroporation, a small subset of cells was cultured in X-VIVO 10 media (as described above) for 5-7 days in order to validate CRISPR/Cas9 efficiency. Genomic DNA was isolated from bulk cells and the CRISPR/Cas9 engineered genomic locus was amplified via PCR as described above.
Sanger sequencing was carried out using the reverse PCR primer and the chromatograms were analyzed using the online tool TIDE Fig. 5d ).
For each transplanted mouse, CRISPR/Cas9 efficiency of control and GATA1-Short edited cells was evaluated in the RF using the same approach. Only mice that showed a CRISPR/Cas9 knock-out efficiency of >90% as determined by the percentage of aberrant sequences after the gRNA cut site and a CD45 + engraftment level in the RF of >5% were utilized in the analysis. Because only one X-chromosome needed to be edited for GATA1-Short, single clonal engraftment was visible based on individual chromatograms (Supplementary Fig. 5e ). GATA1-Short edited LT-HSCs transplanted mice with more than one clone were included into our near-clonal xenotransplantation analysis, as long as the CRISPR/Cas9 knock-out efficiency of >90% and engraftment criteria of >5% were satisfied.
Methylcellulose colony formation assay
1x10^5 cells from the RF of xenotransplanted mice were transferred to 1ml of MethoCult H4034 Optimum methylcellulose medium (StemCell Technologies, 04034) and plated onto a 35mm dish for human specific colony formation. After 10-11 days, individual colonies were collected, washed in PBS and genomic DNA was isolated as described above. Individual CRISPR/Cas9 edits were determined using PCR amplification and Sanger sequencing with the reverse PCR primer as described above.
CRISPR/Cas9 Off-target analysis
Genomic loci that were similar to the gRNA target sequence were identified with Cas0-OFFinder (http://www.rgenome.net/cas-offinder) 35 , using a mismatch number of 2-3 and a DNA/RNA bulge size of 0. Two genomic loci with 2 mismatches were chosen for GATA1-Short gRNA-1, four genomic loci with 3 mismatches for GATA1-Short gRNA-2, four genomic loci with 3 mismatches for GATA1-Long gRNA-1, three genomic loci with 2 mismatches for Control gRNA-1 and one genomic loci with 3 mismatches for Control gRNA-2. PCR primers were designed to amplify 500bp around these genomic loci. 5-10 single cell colonies that were positively identified with the correct CRISPR/Cas9 edit were selected from each cell type and genotype for PCR amplification. PCR products were column purified and subsequent Sanger sequencing with both the forward and reverse PCR primer was carried out.
TIDE analysis was used to assess any CRISPR/Cas9 cleavage efficiency.
Statistical analysis
Error bars represent standard deviations. Statistical significance was assessed using two-tailed unpaired student's t-test.
Additional information on experimental design is available in the Nature Research
Reporting Summary linked to this article.
Data availability
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